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We used affinity-purification mass spectrometry to
identify 747 candidate proteins that are complexed
with Huntingtin (Htt) in distinct brain regions and
ages in Huntington’s disease (HD) and wild-type
mouse brains. To gain a systems-level view of the
Htt interactome, we applied Weighted Correlation
Network Analysis to the entire proteomic data set
to unveil a verifiable rank of Htt-correlated proteins
and a network of Htt-interacting protein modules,
with each module highlighting distinct aspects of
Htt biology. Importantly, the Htt-containing module
is highly enriched with proteins involved in 14-3-3
signaling, microtubule-based transport, and proteo-
stasis. Top-ranked proteins in this module were vali-
dated as Htt interactors and genetic modifiers in an
HDDrosophilamodel. Our study provides a compen-
dium of spatiotemporal Htt-interacting proteins in
the mammalian brain and presents an approach for
analyzing proteomic interactome data sets to build
in vivo protein networks in complex tissues, such
as the brain.
INTRODUCTION
Huntington’s disease (HD) is one of the most common domi-
nantly inherited neurodegenerative disorders clinically charac-
terized by a triad of movement disorder, cognitive dysfunction,
and psychiatric impairment (Bates et al., 2002). HD neuropa-
thology is characterized by selective and massive degenerationof the striatal medium spiny neurons (MSNs) and, to a lesser
extent, the deep layer cortical pyramidal neurons (Vonsattel
and DiFiglia, 1998). The disease is caused by a CAG repeat
expansion resulting in an elongated polyglutamine (polyQ)
stretch near the N terminus of Huntingtin (Htt) (The Huntington’s
Disease Collaborative Research Group, 1993). HD is one of nine
polyQ disorders with shared molecular genetic features, such as
an inverse relationship between the expanded repeat length and
the age of disease onset, and evidence for toxic gain-of-function
as a result of the polyQ expansion (Orr and Zoghbi, 2007).
However, each of the polyQdisorders appears to target a distinct
subset of neurons in the brain leading to disease-specific symp-
toms. Hence, it is postulated that molecular determinants
beyond the polyQ repeat itself may be critical to disease patho-
genesis (Orr and Zoghbi, 2007).
Protein-interacting cis-domains (Lim et al., 2008) and post-
translational modifications (PTMs) of polyQ proteins (Emamian
et al., 2003;Gu et al., 2009) can significantlymodify disease path-
ogenesis in vivo. Thus, studying the proteins that interact with
domains beyond the polyQ region may provide important clues
to diseasemechanisms. In the case of HD, several hundred puta-
tive Htt interactors have been discovered using ex vivo methods,
such as yeast two-hybrid (Y2H) or in vitro affinity pull-down
assays, utilizing only small N-terminal fragments of Htt (Goehler
et al., 2004; Kaltenbach et al., 2007). Such studies have provided
insight intoHtt’s normal function as a scaffolding protein involved
in vesicular and axonal transport and nuclear transcription (Cav-
iston andHolzbaur, 2009; Li andLi, 2006). Thecaveats of theprior
Htt interactome studies include the exclusive use of small Htt
N-terminal fragments as baits and the isolation of interactors
ex vivo. Hence, it is not known which proteins can complex
with full-length Htt (fl-Htt) in vivo within distinct brain regions
and at different ages. Such information may shed light on age-
dependent, selective neuropathogenesis in HD.Neuron 75, 41–57, July 12, 2012 ª2012 Elsevier Inc. 41
Figure 1. Generation and Characterization of a Full-Length Htt In Vivo Proteomic Interactome from BACHD and Wild-Type Mouse Brains
(A) Immunoprecipitation using a human Htt-selective antibody (aa 1,844–2,131, clone HDB4E10) followed by western blot analysis using a human and mouse Htt
antibody (MAB2166) confirms full-length Htt is pulled down in both 2-monthWT and 2- and 12-month BACHD soluble cortical extracts. A negative control (no Htt
antibody) and 5% input loading control were also included.
(B) The affinity purification followed by mass spectrometry (AP-MS) proteomic approach used to identify endogenous fl-Htt protein interactors: (1) The cortex,
striatum, and cerebellum of 2- and 12-month WT and BACHD mice were homogenized; (2) the soluble lysates were subjected to anti-Htt IP using HDB4E10 and
Protein G Dynabeads; (3) the immunoprecipitates were eluted with LDS loading buffer, separated on an SDS-PAGE gel, each gel was cut into 24–27 gel bands,
and each gel band was subjected to in-gel trypsin digestion; (4) approximately 750 independent LC-MS/MS analysis were performed, and (5) all mass spectra
were searched using MASCOT (Matrix Science) to obtain a total of 747 high-scoring, putative Htt-interacting proteins.
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Huntingtin Interactome Network in Mammalian BrainImmunoaffinity purification of native protein complexes
followed by identification of its individual components using
mass spectrometry (MS) has emerged as a powerful tool for
deciphering in vivo neuronal signaling (Husi et al., 2000), and
synaptic and disease-related interactomes (Selimi et al., 2009;
Ferna´ndez et al., 2009). Although a ‘‘shotgun’’ proteomic
approach is useful in creating a list of native-interacting protein
candidates from relevant mammalian tissues, formidable chal-
lenges exist in the unbiased bioinformatic analyses of such
complex proteomic data sets to identify high-confidence inter-
actors and to build accurate, endogenous protein interaction
networks (Liao et al., 2009).
In this study, we performed a spatiotemporal in vivo proteomic
interactome study of fl-Htt using dissected brain regions from
a mouse model for HD and wild-type controls. The BACHD
mouse model used in the study expresses full-length human
mutant Htt (mHtt) with 97Q under the control of human Htt
genomic regulatory elements on a BAC transgene (Gray et al.,
2008). BACHD mice exhibit multiple disease-like phenotypes
over the course of 12 months, including progressive motor,
cognitive, and psychiatric-like deficits and selective cortical
and striatal atrophy (Gray et al., 2008; Menalled et al., 2009).
Our multidimensional affinity purification-mass spectrometry
(AP-MS) study uncovered a total of 747 candidate proteins com-
plexed with fl-Htt in the mammalian brain. Moreover, we applied
WGCNA to analyze the entire fl-Htt interactome data set to
define a verifiable rank of Htt-interacting proteins and to uncover
the organization of in vivo fl-Htt-interacting protein networks
in the mammalian brain.
RESULTS
Building an In Vivo Spatiotemporal Full-Length Htt
Interactome in BACHD and Wild-Type Mouse Brains
To define the in vivo protein interactome for fl-Htt in BACHD and
WTmouse brains, we performed immunoprecipitation (IP) of full-
length mutant and WT Htt from BACHD and control mouse
brains and identified the copurified proteins by mass spectrom-
etry. Since previous studies suggest that themajority of Htt inter-
actors bind to Htt N-terminal fragments, with very few binding to
the C-terminal region (Kaltenbach et al., 2007), we reasoned that
IP with an Htt antibody against the C-terminal region of the
protein should preserve the vast majority of in vivo Htt protein
interactions. We identified a monoclonal antibody (clone
HDB4E10) capable of preferentially pulling down human Htt in
BACHD brains, with lesser affinity for immunoprecipitating
murine Htt in both BACHD andWTmice (Figure 1A). Considering
the lack of suitable Htt antibodies that can immunoprecipitate
only polyQ-expanded or WT Htt with equal efficiency, our(C) The scheme of the spatiotemporal proteomic interactome study that includes
(D) A schematic representation of the Htt tryptic peptides identified along the full-
and WT IP conditions labeled W.
(E) Venn diagram comparison of Htt-interacting proteins identified in this study, l
interacting with ataxia-causing proteins.
(F) Top Ingenuity Pathway Analysis (IPA) canonical signaling pathways enriched
dotted line indicates canonical pathway genome-wide p value significance (p < 0
See also Tables S1, S2, S3, and S5.AP-MS strategy of using HDB4E10 should be considered as a
survey of in vivo Htt-complexed proteins regardless of Htt polyQ
length. This is a reasonable strategy since full-length human
mHtt can fully substitute the essential function of murine Htt in
murine embryonic development (Gray et al., 2008), and hence
both forms should share the majority of in vivo interacting
proteins.
Human and/or murine fl-Htt complexes were immunoaffinity
purified from the cortex, striatum, and cerebellum of BACHD
and WT mice at 2 or 12 months of age using HDB4E10
(Figure 1B). As a negative control, a mock IP for each sample
condition (defined by specific brain region, age, and genotype)
was performed in the absence of the Htt antibody. Therefore,
a total of 30 independent IP experiments were performed, and
approximately 765 trypsin-digested gel slices were subjected
to LC-MS/MS analysis (Figure 1C). Using the MASCOT (Matrix
Science) sequence database-searching tool, we identified a total
of 747 high-scoring, putative Htt-interacting proteins from
BACHD and WT mouse brains (Table S1 available online).
Consistent with the claim that we are surveying fl-Htt-interacting
proteins, we identified Htt peptides spanning the entire
sequence of Htt in both BACHD and WT samples (Figure 1D
and Table S2). As confirmation that HDB4E10 more efficiently
immunoprecipitates human Htt than murine Htt, we observed
more Htt peptides and more extensive sequence coverage of
fl-Htt in BACHD mice compared to WT mice.
The In Vivo fl-Htt Interactome Is Enriched with Known
Htt Interactors and Proteins Involved in Pathways
Relevant to HD
We next performed several standard bioinformatic analyses to
determine the validity of our approach in isolating Htt interactors
in vivo and to define potential biological pathways that Htt may
be engaged in at various ages within different brain regions.
We compared our list of 747 candidates with previously reported
Htt interactors. Among a curated list of 876 proteins previously
identified as putative ex vivo Htt interactors, most of which
were obtained from Y2H experiments (Goehler et al., 2004;
Kaltenbach et al., 2007; http://HDbase.org), we found 139
proteins also present in our in vivo Htt interactome (Figure 1E
and Table S3). This represents a highly significant enrichment
(p = 7.00 3 1050; hypergeometric test). The disease specificity
of our interactome is supported by the comparison of our data
set with that of another polyQ disease protein, Ataxin-1 (Lim
et al., 2006). Despite the fact that one-third of our samples orig-
inated from the cerebellum, the same tissue source as the
Ataxin-1 interactome study, only 38 proteins were present in
both data sets with relatively modest enrichment (p = 0.0005;
Figure 1E and Table S3). Thus, our in vivo fl-Htt interactome30 independent samples for the AP-MS experiments.
length Htt primary sequence (aa 1–3,144). BACHD IP conditions labeled with Q
iterature-curated Htt-interacting proteins, and a published network of proteins
in the the Htt interactome, plotted as log10 p value significance. The black
.05).
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Figure 2. Brain Regional and Age-Specific Protein
Interactions Revealed in Htt Interactome
(A and B) Venn diagram comparison of the age (2- and
12-month) and brain-region-specific (cortex, striatum, and
cerebellum) Htt protein interactions identified in this study.
(C and D) A list of high-confidence age and brain regional
Htt protein interactions (protein identified in >2 IP condi-
tions, >3 total peptides identified, no peptides identified in
control IP).
See also Table S6.
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interacting proteins, both in vivo and ex vivo, for further investi-
gation to determine their roles in Htt biology and HD
pathogenesis.
Gene Ontology (GO) analysis (Huang et al., 2009a, 2009b) of
our in vivo fl-Htt interactome data set (Table S4) showed signifi-
cant overrepresentation of proteins involved in ‘‘Intracellular
Transport,’’ ‘‘Synaptic Transmission,’’ and ‘‘Protein Folding’’
(all previously implicated in HDpathogenesis), as well as proteins
involved in pathways related to the ‘‘Generation of Precursor
Metabolites and Energy,’’ ‘‘Cytoplasmic Membrane-Bound
Organelles,’’ and ‘‘Nucleotide Binding.’’ This supports Htt’s
involvement in multiple biological functions within several
subcellular compartments in the brain (Li and Li, 2006).
We next probed the biological and disease pathways enriched
in our in vivo fl-Htt interactome using Ingenuity Pathway Analysis
(IPA, Ingenuity Systems, http://www.ingenuity.com), a large
curated database of published information on mammalian
biology and disease (Figure 1F; Table S5). As independent vali-44 Neuron 75, 41–57, July 12, 2012 ª2012 Elsevier Inc.dation for the relevancy of our interactome to
HD biology, the IPA ‘‘Huntington’s Disease
Signaling’’ pathway, based on published normal
and disease-specific processes and pathways
relevant to HD, was significantly enriched.
Importantly, other top IPA signaling pathways
enriched in our fl-Htt interactome include
‘‘Protein Kinase A Signaling,’’ ‘‘CREB Signaling
in Neurons,’’ and ‘‘Mitochondrial Dysfunction,’’
which are pathways previously implicated in
HD pathogenesis (Sugars et al., 2004; Kleiman
et al., 2011).
Our rationale for examining samples from
three different brain regions at two different
time points was to reveal dynamic in vivo differ-
ences between fl-Htt interactomes, which
could possibly provide insight into selective,
age-dependent disease processes. To this
end, we identified candidate fl-Htt interactors
exclusively from brain regions or ages relevant
to HD (Figure 2; Table S6), providing an inter-
esting subset of proteins to further investigate
their putative roles in selective neuronal vulner-
ability in HD. While a significant subset of
proteins in our interactome are shared between
all three brains regions (34.9%) and both age
time points (57.2%), a subset of proteinswere found to copurify with Htt in specific brain regions (cere-
bellum, 15.1%; cortex, 23.1%; and striatum, 5.5%) and age
time points (2 months, 20.9% and 12 months, 22.0%). The
proteins that appear reproducibly (at least two peptides in
two IP conditions) and selectively complex with Htt at
12 months, or in the striatum or cortex of our AP-MS data
set, are putative candidates for mediating age-dependent
selective pathogenesis in HD, while those in complex with Htt
only at 2 months or in the cerebellum may be neuroprotective
(Figures 2C and 2D).
Semiquantitative Measures of Protein Abundance Allow
Unbiased Ranking of Candidate Interactors Based
on Correlation with Fl-Htt
Although initial bioinformatics analyses indicated that our fl-Htt
interactome was relevant to HD, we still needed to determine
how to best prioritize the interacting proteins for biological vali-
dation. For this reason, we sought to explore whether the semi-
quantitative MS information embedded within our data set could
Figure 3. Unique Peptide Counts as a Measure of Relative Protein Abundance Reveals Proteins Most Correlated with Htt
(A) The left panel is a western blot analysis using anti-Htt (mAb2166) of the anti-Htt immunoprecipitation (HDB4E10) of 2-month BACHD cerebellum biological
duplicates (Crb2mQ1 and Crb2mQ2, red dashed box), 2-month WT cerebellum biological duplicates (Crb2mW1 and Crb2mW2, blue dashed box), and 2-month
BACHD cerebellum no antibody control (Crb2mBlk). The right panel is a bar graph of unique tryptic Htt peptide counts identified across 30 experimental AP-MS
conditions (right), which illustrate the reproducibility of the number of Htt peptides that is identified in duplicated sample conditions as well as the consistent
variance in across sample conditions (i.e., age, brain region, genotype, and with or without antibody in IP).
(B) Unique peptide counts of the top ten proteins most correlated with Htt across the 30 sample conditions.
(C) Htt correlation bins 1–6 (each consisting of 125 proteins, where bin 1 contains the proteins most correlated with Htt and bin 6 contains the proteins least
correlated with Htt). IPA canonical pathway analysis of these bins showed their enrichment of ‘‘Huntington’s Disease Signaling’’ (plotted aslog10 p values and
the black dotted line indicates p < 0.05). The IPA ‘‘Amyloid Processing Pathway,’’ an Alzheimer’s-disease-related pathway, was used as a negative control. The
number in parentheses indicates the number of proteins identified in each category.
See also Figures S1 and S2 and Tables S7, S8, and S9.
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and enable a rationale prioritization of candidate interactors
for functional studies. We performed a protein spiking experi-
ment by adding increasing concentrations of bovine serum
albumin (BSA) to our BACHD 2-month cortical extracts prior to
LC-MS/MS (Figure S1). Similar to a prior study (Liu et al.,
2004), under our experimental conditions, the unique peptide
counts for BSA were significantly correlated with the known
BSA concentration in different samples (R2 = 0.822). To use
such semiquantitative information to uncover relationships
between candidate interactors and Htt, we took advantage of
the observation that Htt peptide counts were consistently higher
in BACHD samples than in WT control (or blank control) samples
across all 30 IP experiments (Figure 3A). This is because there is
approximately a 2-fold increased level of fl-Htt in BACHD
compared toWT control brains (Gray et al., 2008), and the selec-
tivity of the HDB4E10 for human Htt over murine Htt (Figure 3A).We reasoned that the broadly expressed fl-Htt-interacting
proteins should have relative peptide abundances across
our data set similar to that of Htt (i.e., high in BACHD, low in
WT, and none in the blank). We calculated pairwise correlations
between fl-Htt and the 747 putative-interacting proteins, using
as input the unique tryptic peptide counts identified for each
protein among the 30 sample conditions (Tables S7 and S8).
We found 163 proteins that are significantly correlated with
Htt in our data set (p < 0.05, Table S8), and the top Htt-correlated
proteins consisted of previously known Htt interactors, such
as F8a1 (Hap40), Ndufs3, Ywhae (14-3-3ε), Cct8, Hsp90ab1,
and Cntn1 (Figure 3B; Table S3). Importantly, F8a1/Hap40, a
well-characterized fl-Htt-interacting protein previously impli-
cated in HD pathogenesis (Peters and Ross, 2001), was identi-
fied as being the most significantly correlated with Htt, despite
having three or fewer peptides identified in any given sample
(Tables S7 and S8).Neuron 75, 41–57, July 12, 2012 ª2012 Elsevier Inc. 45
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Htt-correlation ranking to HD biology, we divided the entire
747 candidate Htt-interacting protein pool into six bins of
about 125 proteins, each based on ranking, and annotated
each bin using IPA ‘‘Huntington’s Disease Signaling’’ Pathway.
Interestingly, the results showed a significant correlation
between the fl-Htt correlation ranking and the IPA annotation
of known Htt biology, with the top two bins being the most signif-
icantly enriched with ‘‘Huntington’s Disease Signaling’’ proteins,
while the bottom bins were only marginally or not significantly
enriched (Figure 3C and Table S9). As a control, the top bins of
Htt-correlated proteins are not significantly enriched with an
Alzheimer’s-disease-related IPA pathway (Figure 3C). This
analysis provides independent support of the biological rele-
vance of the Htt correlation ranking of the in vivo fl-Htt
interactome.
Weighted Correlation Network Analysis Organizes the
In Vivo fl-Htt Interactome into Network Modules
The construction of interacting protein networks based exclu-
sively on AP-MS data sets has been largely limited to simple
organisms (e.g., yeast). The use of AP-MS proteomic interac-
tome information derived from complex biological systems to
directly construct protein networks has been a challenge but
an important direction for the field (Vidal et al., 2011). Weighted
Gene Coexpression Network Analysis (WGCNA) (Zhang and
Horvath, 2005) was designed to provide a global analysis of
microarray data across tissues, species, or disease conditions
and to build global gene networks based on coexpression rela-
tionships in order to identify gene modules that are tightly corre-
lated across entire data sets (Miller et al., 2008; Oldham et al.,
2008). However, to date, this method has never been applied
to proteomics data.
Because the semiquantitative data provided by AP-MS pro-
vides a good proxy for relative protein abundance, we applied
WGCNA to our proteomic data set. We call this adapted applica-
tion of the method to protein analysis, Weighted Correlation
Network Analysis (still abbreviated as WGCNA). Briefly, after se-
lecting proteins present in at least three samples (n = 411), the
pairwise correlation coefficients between one protein and every
other detected protein were computed, weighted using a power
function (Zhang and Horvath, 2005; Langfelder and Horvath,
2008), and used to determine the topological overlap, a measure
of connection strength or ‘‘neighborhood sharing’’ in the
network. A pair of nodes in a network is said to have high topo-
logical overlap if they are both strongly connected to the same
group of nodes. In WGCNA networks, genes with high topolog-
ical overlap have been found to have an increased chance of
being part of the same tissue, cell type, or biological pathway.
Our analyses of the fl-Htt interactome produced eight clusters
of highly correlated proteins, or modules, with each including
22–145 proteins (Figure 4A; Table S10). Based on the convention
ofWGCNA (Zhang and Horvath, 2005), themodules were named
with different colors (red, yellow, blue, cyan, pink, green, navy,
and brown).
To investigate the biological underpinning of the WGCNA
modules, we addressed whether eachmodule could have differ-
ential correlation strength with the central protein in our interac-46 Neuron 75, 41–57, July 12, 2012 ª2012 Elsevier Inc.tome, fl-Htt. We computed a Module Eigenprotein (MP) for each
module, which is defined as the most representative protein
member (i.e., a weighted summary) among all proteins in the
module. We then calculated each MP’s correlation with fl-Htt
(Figure 4B and Table S11). The relationship between module
membership (MM, defined as the correlation between each
protein in the network and MP) and fl-Htt levels was determined
(Figures S2A–S2H). Both measures pointed to one module
(red) as the most correlated to fl-Htt across samples, with five
other modules (yellow, blue, cyan, pink, and green) also highly
significantly correlated with fl-Htt. Importantly, the red module
(comprised of 62 proteins, where 19 were previously known
Htt interactors) includes Htt itself, thus giving further support
that the proteins assigned to this module may have important
biological relationships with Htt (Table S12).
To further validate the Htt-correlated modules, we input the
proteins in each module into IPA and analyzed for enrichment
for ‘‘Huntington’s Disease Signaling’’ proteins. The red, blue,
cyan, yellow, green, pink, and navy modules were significantly
enriched with proteins in this pathway (Figure 4C; Table S13).
The brown module was not significantly correlated with Htt and
is also not significantly enriched with IPA HD Signaling proteins
(Figure 4C; Table S13). Together, our analyses support the bio-
logical relevance to Htt of multiple WGCNA modules derived
from our fl-Htt interactome.
Enrichment of Htt Interactome Modules
and Metanetworks in Specific Sample Conditions
We hypothesized that one of the underlying biological relation-
ships driving the formation of different modules could be the
differential enrichment of proteins within distinct AP-MS sample
conditions (e.g., brain region, age, or genotype). To test this, we
correlated the MPs for the six WGCNA modules to the 30
experimental conditions (Figures 5A–5F). We found that red
module is enriched in the cortical and cerebellar samples; the
blue, yellow, and green modules are enriched in the cortical
samples; and the pink module is enriched in the cerebellar
samples. Interestingly, the cyan module appears to be an
age-dependent module, with proteins consistently enriched in
12-month but not 2-month cortical samples in both BACHD
and WT mice (Figure 5F).
Finally, the unbiased process of constructing WGCNA net-
work modules also yields a higher-order metanetwork called
‘‘module eigenprotein network,’’ which can be calculated based
on pairwise correlation relationships of all possible pairs of MPs
(Figure 5G). The two main branches of the network appear to
represent either modules that are enriched with proteins in
cortical samples (red, cyan, blue, green, and yellow) or those
enriched in the cerebellar samples (pink). These analyses
suggest that the hierarchical organization of the fl-Htt interac-
tome modules and their metanetworks may reflect the tightly
correlated group of proteins that preferentially complex with
Htt in distinct sample conditions (brain regions and age).
WGCNA Modules Are Related to Distinct Aspects
of Htt Biology
A key motivation for constructing an unbiased fl-Htt interactome
network is to gain insights into different aspects of Htt molecular
Figure 4. Weighted Correlation Network Analysis of Htt Interactome
(A) Cluster dendrogram generated by hierarchical clustering of proteins on the basis of topological overlap. Modules of correlated proteins were assigned colors
and names (cyan, red, blue, yellow, green, navy, brown, and pink respectively) and are indicated by the horizontal bar beneath the dengrogram, where all
unassigned proteins were placed in the gray module (labeled Color Modules). The number in the color modules represents the number of proteins assigned to
each module. Pairwise correlations were calculated for each protein to the Htt protein, and the p value significance is colored below in the horizontal bar, where
a significant (p < 0.05, red) or nonsignificant correlation (p > 0.05, blue) with Htt protein levels is indicated.
(B) Barplot depicting thelog10 p values of the pairwise correlations between each module’s eigenprotein (see the Supplemental Experimental Procedures) and
Htt. Dotted black line: significance level at p < 0.05.
(C) IPA canonical pathway analysis of eachmodule to show their enrichment of ‘‘Huntington’s Disease Signaling’’ (plotted aslog10 p values values and the black
dotted line indicates p < 0.05).
See also Tables S10 and S11.
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Htt-correlated WGCNA modules using Gene Ontology and IPA
(Tables S13 and S14). HD-relevance and molecular characteris-
tics of each module can be assessed based on their top module
hub proteins, which are defined as the proteins with the highest
correlation with each MP and can be ranked by the module
connectivity values, kwithin (Figure 6 and Table S10).
The red module, which is the most Htt-correlated module and
contains Htt itself, is significantly enriched with hub proteins
involved in unfolded protein binding (i.e., chaperones), 14-3-3
signaling, microtubule-based intracellular transport, and mito-
chondrial function (Figure 6A). Chaperones are key proteins
involved in maintaining a healthy proteome (proteostasis) by
preventing protein misfolding, a pathway directly implicated in
the pathogenesis of neurodegenerative disorders, including HD
(Balch et al., 2008). Several chaperones in the red module
(Tcp1, Hsp90s) have been shown to physically interact with Htt
or modify mHtt toxicity in cell and invertebrate models of HD
(Table 1). The roles of the others remain to be explored.
The second molecular feature of the red module is the pres-
ence of six 14-3-3 family proteins (Ywhab, Ywhae, Ywhag,
Ywhah, Ywhaq, Ywhaz), with Ywhae as a top hub protein (Fig-
ure 6A). Impressively, ‘‘14-3-3-Mediated Signaling’’ in the Red
Module is themost significantly enriched IPACanonical Pathwayfor all modules in the fl-Htt interactome network (Table S13). The
14-3-3 pathway has been implicated in the pathogenesis of
a variety of neurodegenerative disorders (Chen et al., 2003),
and four 14-3-3 members have been shown to physically or
genetically interact with Htt N-terminal fragments (Kaltenbach
et al., 2007; Omi et al., 2008) (Table S3). Since 14-3-3 proteins
are phosphoserine/phosphothreonine binding proteins (Morri-
son, 2009), and Htt phosphorylation at several serine residues
has been shown to modify HD pathogenesis (Humbert et al.,
2002; Gu et al., 2009; Thompson et al., 2009), it could be a prom-
ising direction to investigate whether 14-3-3 proteins in the red
module could directly interact with relevant phospho-Htt species
to affect the disease process.
The third molecular pathway enriched in the red module is
‘‘Intracellular Protein Transport’’ (Dynactin, Dynein, Vcp, and
Ran) consistent with the convergent evidence supporting the
role of Htt function in the microtubule-based transport process
(Caviston and Holzbaur, 2009) and the disruption of such func-
tion in HD (Gauthier et al., 2004).
Although the red module appears to be enriched with proteins
from divergent molecular processes, several lines of evidence
suggest these proteins indeed have close biological connec-
tivity. First, 26 out of the 61 red module proteins are included
in the same IPA network, which is constructed based on theNeuron 75, 41–57, July 12, 2012 ª2012 Elsevier Inc. 47
Figure 5. Enrichment of Htt Interactome Modules and Metanet-
works in Specific Sample Conditions
(A–F) The heatmap correlation profiles (rows) across samples (columns) for
proteins in the following color modules are shown: (A) red, (B) blue, (C) pink, (D)
yellow, (E) green, and (F) cyan, where green indicates areas of low relative
expression profiles and red indicates areas of high relative expression profiles.
The 30 sample conditions are indicated by brain regions, genotype (BACHD
versus WT), and age (2 months, 12 months) or control IP lacking Htt antibody
(Blank or Blk). The two duplicated conditions (two separate columns) are
labeled only once.
(G) Module eigenprotein metanetwork reveals the cortical-enriched subnet-
work and the cerebellum-enriched subnetwork.
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48 Neuron 75, 41–57, July 12, 2012 ª2012 Elsevier Inc.archived IPA Knowledge Base derived from published studies.
This network has the highest IPA network score among all of
the networks constructed from Htt interactome modules (Table
S13), suggesting that the proteins in red module already have
a close functional link based on existing knowledge. Second,
the red module has a marked enrichment for proteins implicated
in other neurological and genetic disorders. Using another IPA
core analysis (IPA Function), the red module has dramatically
higher enrichment for proteins in the categories of Neurological
Disorders andGenetic Disorders compared to the othermodules
(Figures S3A and S3B), which cannot be accounted for by
enrichment of the HD Signaling Pathway alone (Figure 4C).
Furthermore, 16 red module proteins (Figures S3C and S3D)
are mutated in neurological disorders ranging from Frontotem-
poral dementia (Vcp) to Parkinson’s disease (Vps35). Finally,
among the top 50 red module proteins based on module
memberships, there are 19 proteins that are known to interact
with Htt that can modify mHtt toxicity in cell or invertebrate
models of HD (Table 1), and several genes are also known
therapeutic targets for HD (e.g., creatine-targeting Ckb and
17-AAG-targeting Hsp90s) (Herbst and Wanker, 2007; Dorsey
and Shoulson, 2012). In summary, the red module contains
proteins that are highly correlated with Htt (including Htt itself)
and is enriched in a highly connected group of proteins involved
in proteostasis, 14-3-3 signaling, microtubule-based transport,
and mitochondria function.
The second most Htt-correlated module is the blue module,
with its member proteins enriched in the cortex and playing
roles in presynaptic function. The most significant GO terms
enriched in blue module are ‘‘Coated Membrane’’ and ‘‘Neuro-
transmitter Transport’’ (Table S14). The top IPA Canonical
Signaling Pathways enriched in blue module are ‘‘GABA
Receptor Signaling,’’ ‘‘Clathrin-Mediated Endocytosis,’’ and
‘‘Huntington’s Disease Signaling.’’ The hub proteins in blue
module (Ap2a2, Dnm1, and Syt1) are members of a Htt protein
network previously established based on ex vivo interactions
with mHtt fragments and are validated as genetic modifiers in
an HD fly model (Kaltenbach et al., 2007). Together, this
evidence supports the notion that the blue module contains
cortex-enriched Htt interactors that preferentially function in
presynaptic terminals and hence may influence corticostriatal
neurotransmission that is known to be affected in HD (Raymond
et al., 2011).
The pink module is a cerebellum-enriched module with
HD-relevant hub proteins functioning in calcium signaling (Itpr1
and Itpr2), mitochondria function (Ndufa9, Ndufs2, and Uqcrc2),
and glutamate receptor function (Grid2 and Slc1a3). Not surpris-
ingly, several hub proteins are either selectively expressed (Grid2
and Slc1a3) or highly enriched in the cerebellum (Itpr1, Syt2, and
Gpd1; see Allen Brain Atlas). Consistent with the idea that cere-
bellar-enriched Htt interactors may confer neuroprotective func-
tion, one interesting pink module protein, Ucqrc2, was shown to
be one of nine core modulators of the proteostasis network (e.g.,
mHtt polyQ fragment and endogenous metastable proteins) in a
genome-wide Caenorhabditis elegans screen (Silva et al., 2011).
Since our interactome also identified more Ucqrc2 peptides in
brain tissues (cerebellum) and at ages (2 months) relatively unaf-
fected in HD mice (Table S7), this evidence strongly encourages
Figure 6. Functional Annotation of Top Htt-Correlated Modules
(A–F) The network plots, IPA, and GO terms most enriched terms or signaling pathways in the top Htt-correlated modules are shown for the (A) red, (B) blue, (C)
pink, (D) yellow, (E) green, and (F) cyan modules. The key characteristic describing each module is summarized in parentheses. Visant plots are shown repre-
senting the top 150 protein connections in each color module. The enlarged labeled nodes represent the top 15 proteins with the largest module connectivity
values (kwithin) for each module, and the nodes in the middle of each Visant plot are the ‘‘hub genes’’ for each module.
See also Tables S10, S13, and S14.
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Htt in HD selective pathogenesis.
The yellow module is driven by top hub proteins involved in
excitatory postsynaptic function (Table S14). Two of the top
hub proteins (Grin2b/NR2b and Dlg4/PSD95) have been impli-
cated in pathogenesis in HD mice (Zeron et al., 2002; Fan
et al., 2009). Another interesting member, beta-catenin (Ctnnb1),
is a known modifier of mHtt-induced toxicity in HD cell and fly
models (Godin et al., 2010; Dupont et al., 2012). Ctnnb1 is also
a key member of the Wnt signaling pathway, which has been
implicated in multiple neurodegenerative disorders (Wexler
et al., 2011) and is being explored for neuroprotective therapies
(Toledo et al., 2008). Thus, further study of yellow module hub
proteins may yield new therapeutic targets for mitigating post-
synaptic dysfunction in HD.
The green module is highly enriched with proteins involved in
actin cytoskeleton organization (Figure 6E). The annotation ofthis module is consistent with the emerging role of Htt as a direct
actin binding protein (Angeli et al., 2010), with an evolutionarily
ancient function in regulating the actin-binding protein, myosin,
in chemotaxis and cytokinesia (Wang et al., 2011). Greenmodule
hub proteins, including Cdk5 (Anne et al., 2007), Rph3A (Smith
et al., 2007), Rock2 (Shao et al., 2008), and Gja1/Connexin-43
(Vis et al., 1998), have previously been implicated in HD. There-
fore, this module reveals a set of actin binding candidates
that can be studied in the context of normal Htt function and
HD pathogenesis.
Finally, the cyan module is the only age-dependent module
and is also highly enriched with proteins residing in mitochon-
dria, or functioning in inflammation, G protein signaling and
as modifiers of mHtt aggregation. Several of these proteins
(Usp9x, Rock1, and Sirt2) appear to modify mHtt aggregation
or toxicity in cellular models and are known drug targets
(Kaltenbach et al., 2007; Shao et al., 2008; Pallos et al., 2008;Neuron 75, 41–57, July 12, 2012 ª2012 Elsevier Inc. 49
Table 1. Summary of Top 50 Red Module Membership Proteins
Protein Module
Htt





Cntn1 Red 1.000 0.911 Cell adhesion Membrane Known
Atp2b2 Red 1.000 0.907 ATP biosynthesis Membrane This study
Vcp Red 0.999 0.866 DNA repair Cytoplasm f, w
Atp1a1 Red 0.999 0.850 ATP biosynthesis Membrane This study f [this study] Digoxin,
omeprazole
Hsp90ab1 Red 1.000 0.848 Molecular chaperone Cytoplasm f [this study] 17-AAG
Hsp90aa1 Red 0.999 0.804 Molecular chaperone Cytoplasm f 17-AAG
Ckb Red 0.999 0.802 Creatine metabolism Cytoplasm Creatine
Slc12a5 Red 0.999 0.802 Transporter Membrane
Ogdh Red 1.000 0.795 Glycolysis Cytoplasm
Dync1h1 Red 0.999 0.774 Microtubule movement Cytoplasm Known f, w, m
Stx1b Red 0.999 0.771 Neurotransmitter transport Membrane
Dctn1 Red 0.999 0.765 Dynein retrograde
movement
Cytoplasm
Ncam1 Yellow 0.999 0.748 Glycolysis Membrane BB-10901
Camk2b Red 0.999 0.746 Kinase Cytoplasm f [this study]
Ywhae Red 0.999 0.742 Signal transduction Cytoplasm Known f, f [this study]
Cct8 Red 0.999 0.733 Molecular chaperone Cytoplasm Known
Tubb3 Red 0.998 0.727 Microtubule movement Cytoplasm Colchicine,
epothilone B
Tubb4 Red 0.998 0.726 Microtubule movement Cytoplasm Colchicine,
epothilone B
Vps35 Green 0.999 0.723 Transporter Cytoplasm This study f [this study]
Ndufs3 Red 0.999 0.722 Electron transport Cytoplasm Known f [this study]
HTT Red 1.000 0.710 Signaling; transport Cytoplasm
Tcp1 Red 0.997 0.707 Molecular chaperone Cytoplasm Known c, f, f [this study]
Slc3a2 Red 0.998 0.707 Transporter Membrane
Atp1b1 Yellow 0.997 0.694 ATP biosynthesis Membrane Known f [this study]
Ddx5 Green 0.998 0.682 mRNA processing Nucleus
Tuba1b Red 0.998 0.676 Microtubule cytoskeleton Cytoplasm This study
Pdhb Yellow 0.998 0.670 Glycolysis Cytoplasm
Atp2a2 Pink 0.997 0.666 ATP biosynthesis Membrane
Pc Red 0.997 0.664 Gluconeogenesis Cytoplasm
Nefm Yellow 0.996 0.663 Microtubule cytoskeleton Cytoplasm
Sept3 Red 0.998 0.662 Cytokinesis Cytoplasm
Slc25a3 Red 0.998 0.657 Transporter Cytoplasm Known f [this study]
Slc1a3 Pink 0.998 0.657 Transporter Membrane Riluzole
Ywhaz Red 0.997 0.651 Signal transduction Cytoplasm Known c, f
Rplp0 Blue 0.998 0.650 Protein synthesis Cytoplasm w
Nfasc Yellow 0.998 0.650 Cell adhesion Membrane
Tomm70a Yellow 0.996 0.648 Transporter Cytoplasm
Nsf Blue 0.998 0.646 Vesicle-mediated transport Cytoplasm w
Kif1a Green 0.997 0.643 Molecular movement Cytoplasm
Syngr1 Red 0.997 0.643 Synaptic plasticity Membrane
Rad23b Red 0.998 0.632 Nucleotide-excision repair Nucleus
Ap1b1 Green 0.997 0.630 Protein transport Cytoplasm c, w
Cdk5 Green 0.998 0.629 Kinase Nucleus Flavopiridol
Hspa8 Green 0.997 0.626 Molecular chaperone Cytoplasm c, f, w
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Ipo5 Green 0.997 0.621 GTPase inhibitor activity Nucleus f, w
Kif5c Pink 0.998 0.621 Molecular movement Cytoplasm
Atp1a4 Red 0.992 0.621 ATP biosynthesis Membrane Digoxin,
Omeprazole
Ppp2ca Yellow 0.997 0.613 Phosphatase Cytoplasm
Gnao1 Cyan 0.996 0.608 Signal transduction Membrane Known
Stxbp1 Cyan 0.997 0.607 Exocytosis Cytoplasm Known f
Protein function, subcellular distribution, and drug annotation was based on Ingenuity Pathway Analysis (IPA). ‘‘This study’’ indicates protein interac-
tors that are validated by coimmunoprecipitation and western blot analysis, and by fly genetic modifiers. Previously identified Htt interactors are
labeled as ‘‘Known’’, and previously identified genetic modifiers (c, cells; f, fly; w, worm; m, mouse) are indicated above. See the Supplemental Infor-
mation for a complete list of references.
See also Figure 7 and Figure S4.
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influencing mHtt aggregation gained further support after a
genome-wide RNA interference screen for modifiers of mHtt
aggregation identified a number of similar genes, including
Aldoa, Csnk2a1, Hspa9, Pfkm, and Rab1a in Drosophila cells
(Zhang et al., 2010). Thus, the cyan module is enriched with
proteins complexed with Htt in an age-dependent manner,
which may help to probe the poorly understood role of aging in
the pathogenesis of HD.
Experimental Validation of Red Module Proteins
as Huntingtin Interactors and Genetic Modifiers
of Functional Deficit in a Fly Model of HD
We next sought to validate those proteins not previously impli-
cated in HD but with a high red module connectivity (hub
proteins) as Htt physical interactors and/or genetic modifiers
(Table 1). We performed an anti-Htt co-IP from BACHD and
WT mouse brains followed by western blot analysis for the
specific candidate proteins to confirm interaction (Figure 7A).
We confirmed six proteins (Atp1a1, Atp2b2, Cct8, Cct1, Tuba1b,
and Cntn1) and one positive control red module protein (Hap40/
F8A1) as coimmunoprecipitating with Htt. Furthermore, Vps35,
a protein in the retromer complex that functions in the retrieval
of certain membrane proteins from the endosome to the plasma
membrane (Attar and Cullen, 2010), was found in both the IP of
Htt in both the BACHD andWTmouse brain extracts (Figure 7B).
Moreover, Htt is also present in the reciprocal co-IP of Vps35
from these brain extracts (Figure 7B). Thus, the top red module
proteins are indeed complexed with Htt in the mouse brain.
To test the hypothesis that red module proteins are also modi-
fiers of mHtt toxicity in vivo, we performed a genetic modifier
study using an established Drosophila model of HD expressing
a human Htt fragment (amino acids 1–336) with an expanded
polyQ repeat of 128 glutamines (NT-Htt[128Q]) (Kaltenbach
et al., 2007). Directed expression of NT-Htt[128Q] to all neurons
in the CNS results in a robust and progressive motor deficit that
can be quantified in a climbing assay. We used this behavioral
assay to test 32 redmodule genes for which there were available
mutants in the correspondingDrosophila ortholog genes, andwe
were able to validate 12 red module hub proteins as modifiers ofneuronal dysfunction (Figures 7C–G; Figures S4A–S4J). Among
the genetic enhancers of the HD motor deficits are Atp1b1,
Camk2b, Ndufs3, Tcp1/Cct1, Ywhae, and Ywhag. The genetic
suppressors are Atp1a1, Gnai2, Hsp90ab1, Hspd1, Ndufs3,
Vps35, and Slc25a3. Interestingly, Ndufs3 is both a suppressor
when overexpressed and an enhancer by partial loss of function,
demonstrating dosage-sensitive modulation of mHtt-induced
motor deficits. In summary, our validation studies confirmed
seven red module proteins as Htt-complexed proteins in vivo
and 12 red module proteins as genetic modifiers in HD fly. By
integrating our validation studies with the existing HD literature,
we found a total of 25 out of the top 50 red module proteins
(based on MM of red module (MMred)) to physically or geneti-
cally capable of interacting with Htt in various HDmodel systems
(Table 1), lending further support that the red module is a central
Htt in vivo protein network, mediating critical aspects of normal
Htt function and HD pathogenesis in the brain.
DISCUSSION
We have used an AP-MS approach to obtain the first compen-
dium of spatiotemporal full-length Htt-interacting proteins in
the mammalian brain, with the identification of 747 candidate
proteins that complex with fl-Htt in vivo, creating one of the
largest in vivo proteomic interactome data sets to date and
directly validating more than 100 previously identified ex vivo
interactors shown to associate with small N-terminal Htt frag-
ments. We have also provided information on the context (age
or brain regions) in which these proteins associate with fl-Htt.
Moreover, we were able to unbiasedly rank the interacting
proteins, based on their correlation strength with Htt, and to
construct a WGCNA network that describes this interactome.
Proteins in several WGCNA network modules are highly corre-
lated with Htt itself and appear to reflect distinct biological
contexts in their interactions with Htt. Finally, we were able to
validate 18 red module proteins as in vivo physical interactors
or genetic modifiers in an HD fly model. In summary, our study
provides the first comprehensive survey of proteins complexed
with fl-Htt in distinct brain regions at different ages and
demonstrates a conceptually novel but simple approach toNeuron 75, 41–57, July 12, 2012 ª2012 Elsevier Inc. 51
Figure 7. Validation of RedModule Proteins in Htt Interactome Uncovers Htt-Interacting Proteins in WT and BACHDMice and Novel Genetic
Modifiers of Disease in a Fly Model of HD
(A) Coimmunoprecipitation of top MMred proteins from 2-month WT and BACHD mouse brains. Htt was immunoprecipitated with anti-Htt (clone HDB4E10) and
probedwithmousemonoclonal antibodyMAB2166. The 10% input for each protein (left panels) and resulting immunoprecipitations are shown (right panels). A no
Htt antibody negative control was performed in parallel to confirm specific protein interaction. F8a1 (Hap40) served as the positive control for Htt protein
interaction.
(B) Reciprocal coimmunoprecipitation of Htt and Vps35 in 2-month WT and BACHD mouse brains. Anti-alpha tubulin was used as a loading control.
(C) Table summarizing the effects caused by modulating the levels of the indicated red module proteins on NT-Htt[128Q]-induced motor performance in a HD
Drosophila model.
(D–G) Charts represent motor performance as a function of age. Each chart includes controls (elav-GAL4) and animals expressing NT-Htt[128Q] either alone or
together with a loss-of-function allele targeting theDrosophila homolog of the indicated gene (red continuous lines). Control flies show robust motor performance
for the duration of the experiment (black dashed line). Animals expressing NT-Htt[128Q] in the nervous system using elav-GAL4 show a progressive decline in
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AP-MS data from tissues as complex as the mammalian brain.
This study highlights core HD-relevant molecules and path-
ways via integration of our spatiotemporal fl-Htt interactome
with previously generated Htt ex vivo interactome and cell- or
invertebrate-based genetic modifier data sets, many of which
are archived in IPA’s ‘‘Huntington’s Disease Signaling’’ pathway.
We show that 139 previously identified ex vivo Htt interactors
(e.g., Y2H) also complex with fl-Htt in the mammalian brain
(Goehler et al., 2004; Kaltenbach et al., 2007). Moreover,
comparison of our interactome with data sets derived from
genetic modifier screens in Drosophila and C. elegans models
of HD may also help identify proteins that can interact with
mHtt in the mammalian brain and possibly modify its toxicity
and could be prioritized for further validation in mammalian
models of HD. For example, comparison of our data set with
data obtained from genetic screens in yeast, C. elegans, and
fly models of HD (Nollen et al., 2004; Wang et al., 2009; Zhang
et al., 2010; Silva et al., 2011) reveal several red module (CCTs,
Hsp90s, 14-3-3 s, and Vcp; Table 1) and pink module (Uqcrc2)
proteins in common, which could possibly represent evolution-
arily conserved modifiers of mHtt-induced toxicity. Therefore,
their disease-modifying role should be fully explored in HD
mammalian models.
A keymotivation for this workwas to obtain an unbiased global
view of complex biological function or disease processes
related to fl-Htt protein in the intact brain and to formulate test-
able hypotheses. The first crucial insight obtained from our
WGCNA analyses is that distinct Htt-correlated modules
represent proteins preferentially complexed with Htt in specific
sample conditions that reflect distinct biological context,
cortical samples (red, blue, yellow, and green modules), cere-
bellar samples (pink module), and 12-month but not 2-month
cortical samples (cyan module). The second important insight
is that each of the six significant modules provides critical
aspects of known Htt and HD biology. All are significantly
enriched with ‘‘Huntington’s Disease Signaling’’ in IPA (Fig-
ure 6C). Knowing the architecture and Htt-relevance of each
network module can seed hypotheses based on important
hubs and/or molecular or pathogenic processes defined by the
module, for example, Cntn1 and Vcp in red-module-mediating
mHtt toxicity; Rad23b in red module implicating specific DNA
repair and ubiquitin/proteasome pathway in Htt biology; Sirt2,
Cox2, and Usp9x in the cyan module in age-dependent patho-
genesis; and Itpr1 and Grid2 in cerebellar neuroprotection in
HD. Testing such hypotheses will constitute a crucial next step
toward unraveling the complex biology of Htt in healthy and
diseased brains but also further deciphering the biological signif-
icance of the in vivo Htt protein network.
One potentially exciting area of data integration would be to
combine proteomic interactome data with large-scale genetic
modifier/gene expression profiling studies from HD patients.their motor performance (blue dashed lines). (D and G) show the suppressor effec
(E and F) show the enhancer effect of decreasing the levels of theDrosophila homo
(SEM). Two experimental replicates are shown for the NT-Htt128Q and the NT-H
See also Figure S4.The increasing capacity of DNA sequencing provides an unprec-
edented opportunity for such large-scale studies using patient
samples, and our fl-Htt brain interactome may provide
converging information on candidates that may have both a
genetic and proteomic link to Htt. Thus, our study lends strong
support to a systems biology strategy of vertically integrating
large genetic, genomic, and interactome data sets (Geschwind
and Konopka, 2009) derived from HD models of different organ-
ismal complexity to unravel the conserved mechanism related to
Htt biology and HD pathogenesis.
Our study supports the view that themajority of Htt-interacting
proteins are relatively stable across brain tissue and age (Figures
2A and 2B), while a portion of the Htt interactome is quite
dynamic. The latter group of proteins, particularly those that
consistently complex with mHtt in a brain-regional-specific or
age-specific manner (Figures 2C–2D), could be interesting
candidates to study for their contribution to selective neuronal
vulnerability and age-dependent pathogenesis in HD. Our
studies also raised the intriguing possibility that age-dependent
changes in the normal brain proteome (e.g., Sirt2) may alter
Htt interactions, which could in turn contribute to the presently
unexplained role of aging in disease pathogenesis (Maxwell
et al., 2011).
A major advance in this study is the use of a systems biology
approach to construct in vivo protein interaction networks exclu-
sively using proteomic interactome data sets generated from
complex tissue.We applied, for the first time,WGCNA to analyze
all the unique peptide count information for an entire group of Htt
complexed proteins in our spatiotemporal AP-MS data set.
WGCNA provides an unbiased systems-level organization of
gene expression modules in both normal and diseased brains
(Voineagu et al., 2011) and has been demonstrated to be among
the most powerful methods for global network construction
(Allen et al., 2012). Several lines of evidence support the validity
and value ofWGCNA analyses of our in vivo Htt interactome data
set. We were able to show that the pairwise correlation measure
leads to ameaningful ranking of Htt-related proteins with respect
to the external annotated knowledge of HD-related proteins
(Huntington’s Disease Signaling in IPA; Figure 3C). WGCNA
identified six significant Htt-correlated modules with distinct
tissue- or age-specific overrepresentation and significant
enrichment of distinct biological function previously implicated
in Htt biology (Figure 6), effectively providing an in silico dissec-
tion of the molecular processes related to fl-Htt biology.
Several experimental factors were instrumental to the
construction of WGCNA networks based on our AP-MS data
set. First, the relative level of bait protein (fl-Htt) brought down
by IP is markedly, but reproducibly, variable across all samples.
Such variation is due to our experimental design of using
samples from distinct brain regions, ages, genotypes, and no-
antibody controls and also from the use of an anti-Htt antibody
that preferentially binds to human over murine Htt. Thet of decreasing the levels of the Drosophila homologs of Vps35 and Hsp90ab1.
logs of Ywhae and Tcp1/Cct1. Error bars represent standard error of the mean
tt128Q/modifier animals except for (G).
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sample results in a similar quantitative variation for those
proteins that were tightly associated with Htt (i.e., highly corre-
lated with Htt), while background proteins (false positives) in
the sample are less likely to vary in a similar manner as Htt.
Hence, rather than being weakened by experimental variance,
WGCNA was able to extract the quantitative correlation relation-
ships among the proteins identified in our study. The second
important factor for WGCNA analyses was the large-scale and
multidimensional nature (e.g., brain region, age, and genotype)
of our study. We estimated that one would need at least 24 inde-
pendent AP-MS experiments (at least one biological replicates
per sample condition), with systematic changes in the sample
conditions to create differential pulldown of the bait protein
and its complexes, in order to construct a robust WGCNA
protein interaction network. One caveat of the current study is
our use ofMSunique tryptic peptide counts as a semiquantitative
readout of relative protein abundance. Such limitation could
have been resolved by using stable isotope labeling in intact
animals for a quantitative AP-MS study (Kru¨ger et al., 2008).
Finally, our analysis provides a central molecular network, the
red module, which is likely to contain proteins crucial to Htt
biology and may constitute novel molecular targets to study for
HD pathogenesis and therapeutics. The red module has Htt as
its member and is highly enriched with previously known Htt
interactors and genetic modifiers (Table 1). We were able to
validate seven red module proteins as in vivo Htt interactors by
co-IP (Figure 7) and 12 as modifiers of Htt-induced neuronal
dysfunction in a flymodel (Figure 7; Figures S4A–S4J). Moreover,
red module proteins are targets for small molecules that are in
HD clinical trials (i.e., creatine-targeting Ckb; Hersch et al.,
2006) or show effectiveness in preclinical studies in HD or other
polyglutamine disorders in mice (Waza et al., 2005; Masuda
et al., 2008). Considering several other proteins in this module
can also be targeted by small molecules (Table 1), it would be
interesting to explore whether pharmacological targeting of
these proteins could be therapeutic in HD preclinical models.
In conclusion, we have constructed the first compendium of
in vivo fl-Htt-interacting proteins in distinct brain regions and
ages, thereby providing a valuable resource for further explora-
tion of the normal function of Htt in several disease-relevant
biological context and for identification of novel molecular
targets critical to HD pathogenesis and therapeutics. Moreover,
we have demonstrated an innovative approach utilizing WGCNA
to analyze multidimensional AP-MS data sets to produce in vivo
protein networks and validated multiple key proteins in the
network. This powerful application of systems biology to proteo-
mics can be readily applied to decipher in vivo protein networks
for other normal or disease proteins in tissues as complex as the
mammalian brain.
EXPERIMENTAL PROCEDURES
See the Supplemental Experimental Procedures for additional details.
Mouse Breeding, Maintenance, and Genotyping
BACHD mice were bred, maintained in the FvB/NJ background, and geno-
typed as previously described (Gray et al., 2008). BACHD mice were main-
tained under standard conditions consistent with the National Institutes of54 Neuron 75, 41–57, July 12, 2012 ª2012 Elsevier Inc.Health guidelines and approved by the University of California, Los Angeles,
Institutional Animal Care and Use Committees.
Brain Tissue Lysate Preparation and Anti-Htt Immunoprecipitation
Protein was prepared as previously described (Gu et al., 2009). Briefly, BACHD
and WT mouse brains were dissected in ice-cold 100 mM PBS and homoge-
nized in modified RIPA buffer supplemented with Complete Protease Inhibitor
Mixture tablets (Roche, Indianapolis, IN, USA) using ten strokes from a
Potter-Elvehjem homogenizer followed by centrifugation at 4C for 15 min at
16,000 3 g. The resultant supernatant is the soluble fraction and protein
concentrations were determined using the Bio-Rad Protein Assay (Bio-Rad,
Hercules, CA, USA). Brain lysates (2.5 mg) were subjected to immunoprecip-
itation with anti-huntingtin clone HDB4E10 (MCA2050, AbD Serotec, 1:500)
using Protein G Dynabeads (Invitrogen, Carlsbad, CA, USA). Immunoprecipi-
tated proteins (500 mg) were washed, eluted with NuPAGE LDS loading buffer,
and subjected to western blot analysis.
In-Gel Trypsin Digestion
Immunoprecipitated protein samples were separated on NuPAGE 3%–8%
Tris-Acetate gels (Invitrogen), stained using GelCode Blue stain reagent
(Thermo Fisher Scientific, Rockford, IL, USA), destained in ddH2O, and
then cut into approximately 24–27 gel slices. The gel slices were washed
three times in alternating solutions of a 50:50 mix of 100 mM NaHCO3
buffer/CH3CN and 100% CH3CN. Disulfide bonds were reduced by incuba-
tion in 10 mM dithiothreitol (DTT) at 60C for 1 hr. Free sulfhydryl bonds were
blocked by incubating in 50 mM iodoactamide at 45C for 45 min in the
dark, followed by washing three times in alternating solutions of 100 mM
NaHCO3 and CH3CN. The slices were dried and then incubated in a
20 ng/ml solution of porcine trypsin (Promega, Madison, WI, USA) for
45 min at 4C, followed by incubation at 37C for 4 to 6 hr. Afterwards,
the supernatant was transferred into a fresh collection tube. The gels were
incubated for 10 min in a solution of 50% CH3CN/1% trifluoroacetic acid
(TFA), in which the supernatant was removed and combined with the previ-
ously removed supernatants. This step was repeated a total of three times.
The supernatant samples containing the peptides were then spun to dryness
and prepared for LC-MS/MS analysis by resuspension in 10 ml of 0.1%
formic acid.
Mass Spectrometry Analysis
Peptide sequencing was accomplished by nanoLC-MS/MS with a QqTOF-
MS (QSTAR Pulsar XL, Applied Biosystems, Foster City, CA, USA) equipped
with nanoelectrospray interface (Protana, Odense, Denmark) and LC Pack-
ings (Sunnyvale, CA, USA) nano-LC system. The nano-LC was equipped
with homemade precolumn (150 3 5 mm) and analytical column
(75 3 150 mm) packed with Jupiter Proteo C12 resin (particle size 4 mm,
Phenomenex, Torrance, CA, USA). The dried peptides were resuspended
in 1% formic acid (FA) solution. Six microliters of sample solution was
loaded to the precolumn for each LC-MS/MS run. The precolumn was
washed with the loading solvent (0.1% FA) for 4 min before the sample
was injected onto the LC column. The eluents used for the LC were 0.1%
FA (solvent A) and 95% ACN containing 0.1% FA (solvent B). The flow
rate was 200 nl/min, and the following gradient was used: 3% B to 35%
B in 72 min, 35% B to 80% B in 18 min, which was maintained at 80% B
for 9 min. The column was finally equilibrated with 3% B for 15 min prior
to the next run. Electrospray ionization was performed using a 30 mm
(i.d.) nanobore stainless steel online emitter (Proxeon, Odense, Denmark)
and a voltage set at 1900 V. Sequences were searched against Swiss-
Prot mouse and mammalian genomes using MASCOT software versions
2.1.0 and 2.1.04 (Matrix Science, London, UK). Peptides were required to
have a rank = 1 and a score >18.
Weighted Correlation Network Analysis and Module Detection
We constructed a weighted correlation network as previously described using
the R software package (Langfelder andHorvath, 2008). We used proteins with
unique tryptic peptide counts coming from at least three IP conditions as an
input (n = 411). See Supplemental Experimental Procedures for complete
WGCNA procedure.
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Using a population of 15 age-matched (± 4 hr) virgin female flies, we estimated
the percentage of animals able to climb past a line set at 9 cm in 15 s. These
tests were repeated ten consecutive times for each replicate per experimental
day. The experiment was carried out in duplicate (two populations of
15 animals) in flies that were 8, 10, 12, 14, and 16 days old. Tests were always
performed in the same time of the day and in the same place to avoid circadian
rhythm and environmental variability. The average number of flies climbing per
day is averaged and plotted independently for each replicate.
Statistical Analysis
All values are presented as the mean ± SEM, and p < 0.05 was considered
statistically significant.
SUPPLEMENTAL INFORMATION
Supplemental Information includes four figures, 14 tables, and Supplemental
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